Costly Biotech Bet Still Worth It for J&J

A deal for Actelion Pharmaceuticals would help Johnson & Johnson generate growth.

Popular Posts


(Visited 6 times, 1 visits today)

Vote on this story -->>>

this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami